Morning Briefing
Summaries of health policy coverage from major news organizations
When It Comes To Cosmetic Products' Safety, FDA's Hands Are Tied. Some Want To Change That.
When the Los Angeles hairstylist Chaz Dean pitched his almond mint and lavender-scented hair care products 鈥 endorsed by celebrities like Brooke Shields and Alyssa Milano 鈥 he sold millions. But his formula got an unexpected result: itching, rashes, even hair loss in large clumps, in both adults and children. More than 21,000 complaints have been lodged against his Wen Hair Care, and Mr. Dean, the blue-eyed, golden-haired stylist to the stars, has found himself at the center of a fierce debate over the government鈥檚 power to ensure the safety of a cosmetics industry with about $50 billion in annual sales. (Lipton and Abrams, 8/15)
In other FDA news聽鈥
Yet the legal challenge is not over for Medtronic. The company, one of the world鈥檚 largest medical device manufacturers, now faces a whistleblower lawsuit that claims it sought Food and Drug Administration approval for its devices under false pretenses 鈥 and that the devices have been regularly used for a purpose that was never intended by regulators. 鈥淭hey were labeled, 鈥榥ot for cervical spine use,鈥 and yet in everything about them, including emails from their marketing folks, it makes clear that they were meant to be and were used in the cervical spine,鈥 said Dr. Vikas Saini, president of the Lown Institute, a Boston health care think tank, who has followed the case. (Kaplan, 8/15)